TB500 Thymosin Beta 4 (TB4)
TB500
CAS: 885340-08-9
Molecular Formula: C38H68N10O14
TB500 Thymosin Beta 4 (TB4) - Names and Identifiers
| Name | TB500 |
| Synonyms | TB500 TB500 fragment TB500 fragment acetate TB500 Thymosin Beta 4 (TB4) L-Glutamine, N-acetyl-L-leucyl-L-lysyl-L-lysyl-L-threonyl-L-α-glutamyl-L-threonyl- |
| CAS | 885340-08-9 |
TB500 Thymosin Beta 4 (TB4) - Physico-chemical Properties
| Molecular Formula | C38H68N10O14 |
| Molar Mass | 889.02 |
| Density | 1.281±0.06 g/cm3(Predicted) |
| Boling Point | 1405.0±65.0 °C(Predicted) |
| pKa | 3.20±0.10(Predicted) |
TB500 Thymosin Beta 4 (TB4) - Introduction
TB500 is a biologically active polypeptide consisting of a fragment of Thymosin β4 protein, which is obtained by acetic acid esterification. It has properties that promote wound repair and tissue regeneration.
TB500 is widely used in research and clinical practice. Its Main uses include wound repair, tissue regeneration, treatment of chronic ulcers, and rehabilitation of muscle and bone injuries.
Preparation method, the preparation of TB500 is usually obtained by chemical synthesis method. First, the Thymosin β4 protein molecules were subjected to acetic acid esterification reaction, and then the final TB500 was obtained through purification, structural identification and other steps.
Regarding safety information, TB500 is generally considered to have high safety. However, it is still necessary to operate in accordance with relevant laboratory and clinical practices, and follow appropriate dosage and usage to ensure the safety and effectiveness of use. In case of allergic reactions or other adverse reactions, discontinue use immediately and consult a doctor. In addition, for certain groups of people, such as pregnant women, children, or patients with certain diseases, it is necessary to consult a doctor and understand the relevant risks and precautions before use.
TB500 is widely used in research and clinical practice. Its Main uses include wound repair, tissue regeneration, treatment of chronic ulcers, and rehabilitation of muscle and bone injuries.
Preparation method, the preparation of TB500 is usually obtained by chemical synthesis method. First, the Thymosin β4 protein molecules were subjected to acetic acid esterification reaction, and then the final TB500 was obtained through purification, structural identification and other steps.
Regarding safety information, TB500 is generally considered to have high safety. However, it is still necessary to operate in accordance with relevant laboratory and clinical practices, and follow appropriate dosage and usage to ensure the safety and effectiveness of use. In case of allergic reactions or other adverse reactions, discontinue use immediately and consult a doctor. In addition, for certain groups of people, such as pregnant women, children, or patients with certain diseases, it is necessary to consult a doctor and understand the relevant risks and precautions before use.
Last Update：2024-04-09 21:48:26
